Tadalafil Tablet
Product Images NDC 43547-032

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 43547-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F35596a7-figure-01 (F35596a7 Figure 01)

FDA Label Image

F35596a7-figure-02 (F35596a7 Figure 02)

This text provides information on blood pressure measurements including standing and supine diastolic and systolic values. It also includes a reference to time in hours for the measurements.*

FDA Label Image

F35596a7-figure-03 (F35596a7 Figure 03)

This text appears to show a graph or chart depicting standing systolic blood pressure (BP) in millimeters of mercury (mmHg). It may also include information about the use of Tadalafil 20 mg & doxazosin 8 mg.*

FDA Label Image

F35596a7-figure-04 (F35596a7 Figure 04)

This information displays systolic blood pressure measurements taken at different times after the administration of tadalafil or placebo in combination with doxazosin. The readings provide insights into the effects of the medications on blood pressure levels over time.*

FDA Label Image

F35596a7-figure-05 (F35596a7 Figure 05)

FDA Label Image

F35596a7-figure-06 (F35596a7 Figure 06)

The text describes the results of a study comparing the change in IPSS total score between Tadalafil tablets 5 mg and a placebo over a duration of 12 weeks of treatment. The data suggests a statistically significant difference between the two groups, with a p-value of less than 0.001.*

FDA Label Image

F35596a7-figure-07 (F35596a7 Figure 07)

This text appears to be a table showing the comparison between Tadalafil tablets 5 mg and placebo over a duration of treatment in weeks. The table includes data points and significance levels (p<0.01). It provides a visual representation of the efficacy or outcomes of using Tadalafil tablets 5 mg compared to a placebo over the specified treatment period.*

FDA Label Image

F35596a7-figure-08 (F35596a7 Figure 08)

LS Mean Change from Baseline for TadalafilFinasteride vs PlaceboFinasteride. This data could be related to a clinical trial or study comparing the treatment effects of TadalafilFinasteride versus PlaceboFinasteride based on the least squares treatment difference.*

FDA Label Image

F35596a7-figure-09 (F35596a7 Figure 09)

This text provides information about a study comparing Tadalafil tablets at a dosage of 5 mg to a placebo. The study shows a statistically significant difference with a p-value of <0.01 over a duration of treatment ranging from 0 to 12 weeks.*

FDA Label Image

2.5 mg Strengrh (F35596a7 Figure 10)

This is a prescription medication containing 2.5 mg of adalafil, USP. The tablets should be stored at room temperature. Manufactured by Princeton Laboratories in Charlotte, NC, and distributed by Soico Healthcare US, LLC. Do not split the tablets. Each bottle contains 30 tablets. Please refer to the provided dosage instructions for proper use.*

FDA Label Image

5 mg Strengrh (F35596a7 Figure 11)

This is a description for tablets distributed under the NDC 43547-031-03. The tablets are QEGEIE Tablets, USP and come in a pack of 30 tablets. It is indicated not to split the tablets, and the entire dose should be taken. The tablets have a size of 0.75" x 1.25" and do not have a coating.*

FDA Label Image

10 mg Strengrh (F35596a7 Figure 12)

This is a description of the product: Tablets, USP. Each tablet has to be taken whole and should not be split. The package contains 30 tablets without any coating. The tablets are distributed under the National Drug Code 43547-032-03.*

FDA Label Image

20 mg Strength (F35596a7 Figure 13)

This text provides information about a medication containing 20 mg of tadalafil, USP. It includes details on storage conditions (20°C to 25°C), dosage instructions, and a manufacturer's name (Prinston Laboratories) and distributor's name (Solco Healthcare US, LLC). The text also mentions a website for drug labeling information and provides a National Drug Code (NDC) number (43547-033-03).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.